News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Staff September 11, 2023 Iframe sync Post navigation Previous: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T RelapseNext: EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 More Stories Brain Healthcare Hospitals News Pharmaceutical MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics Staff December 23, 2025 Brain Healthcare Hospitals News Pharmaceutical MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics Staff December 23, 2025 Healthcare News MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi Staff December 23, 2025
